• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mechanisms of disease: Inborn errors of bile acid synthesis.疾病机制:胆汁酸合成的先天性代谢缺陷
Nat Clin Pract Gastroenterol Hepatol. 2008 Aug;5(8):456-68. doi: 10.1038/ncpgasthep1179. Epub 2008 Jun 24.
2
Inborn errors of bile acid metabolism in Japan.日本胆汁酸代谢先天性缺陷。
Pediatr Int. 2023 Jan;65(1):e15490. doi: 10.1111/ped.15490.
3
Identification of a new inborn error in bile acid synthesis: mutation of the oxysterol 7alpha-hydroxylase gene causes severe neonatal liver disease.胆汁酸合成中一种新的先天性代谢缺陷的鉴定:氧化甾醇7α-羟化酶基因突变导致严重的新生儿肝病。
J Clin Invest. 1998 Nov 1;102(9):1690-703. doi: 10.1172/JCI2962.
4
Disorders of bile acid synthesis.胆汁酸合成障碍。
J Inherit Metab Dis. 2011 Jun;34(3):593-604. doi: 10.1007/s10545-010-9259-3. Epub 2011 Jan 13.
5
AKR1D1 and CYP7B1 mutations in patients with inborn errors of bile acid metabolism: Possibly underdiagnosed diseases.AKR1D1 和 CYP7B1 基因突变与胆汁酸代谢先天性错误:可能被低估的疾病。
Pediatr Neonatol. 2020 Feb;61(1):75-83. doi: 10.1016/j.pedneo.2019.06.009. Epub 2019 Jul 4.
6
Neonatal cholestasis with increased 3β-monohydroxy-Δ⁵ bile acids in serum and urine: not necessarily primary oxysterol 7α hydroxylase deficiency.血清和尿液中 3β-单羟基-Δ⁵ 胆汁酸增加的新生儿胆汁淤积:不一定是原发性氧化固醇 7α 羟化酶缺乏症。
Clin Chim Acta. 2012 Oct 9;413(19-20):1700-4. doi: 10.1016/j.cca.2012.05.016. Epub 2012 May 28.
7
Inborn Errors of Bile Acid Metabolism.先天性胆汁酸代谢紊乱。
Clin Liver Dis. 2018 Nov;22(4):671-687. doi: 10.1016/j.cld.2018.06.006. Epub 2018 Aug 22.
8
[Clinical features of a Chinese infant with inborn error of bile acid metabolism-3β-hydroxy-Δ(5)-C27-steroid dehydrogenase deficiency and review of the literature].[一名患有胆汁酸代谢先天性缺陷——3β-羟基-Δ(5)-C27-类固醇脱氢酶缺乏症的中国婴儿的临床特征及文献复习]
Zhonghua Er Ke Za Zhi. 2013 Aug;51(8):625-9.
9
Liver disease caused by failure to racemize trihydroxycholestanoic acid: gene mutation and effect of bile acid therapy.因三羟基胆烷酸消旋失败所致的肝病:基因突变及胆汁酸疗法的效果
Gastroenterology. 2003 Jan;124(1):217-32. doi: 10.1053/gast.2003.50017.
10
Inborn errors of bile acid metabolism.先天性胆汁酸代谢异常
J Inherit Metab Dis. 1991;14(4):478-96. doi: 10.1007/BF01797919.

引用本文的文献

1
Cholic acid as a treatment for cerebrotendinous xanthomatosis: a comprehensive review of safety and efficacy.胆酸治疗脑腱黄瘤病:安全性和有效性的全面综述
Orphanet J Rare Dis. 2025 Jul 29;20(1):387. doi: 10.1186/s13023-025-03889-9.
2
Effectiveness and Safety of Personalized Cholic Acid Treatment in Patients With Bile Acid Synthesis Defects.个性化胆酸治疗对胆汁酸合成缺陷患者的有效性和安全性
J Inherit Metab Dis. 2025 Jul;48(4):e70062. doi: 10.1002/jimd.70062.
3
The Spatial Transcriptional Activity of Hepatic TCF7L2 Regulates Zonated Metabolic Pathways that Contribute to Liver Fibrosis.肝脏中TCF7L2的空间转录活性调节有助于肝纤维化的区域化代谢途径。
Nat Commun. 2025 Apr 10;16(1):3408. doi: 10.1038/s41467-025-58714-5.
4
Molecular dynamics, docking and quantum calculations reveal conformational changes influenced by CYP271A amino acid mutations related to cerebrotendinous xanthomatosis.分子动力学、对接和量子计算揭示了与脑腱黄瘤病相关的CYP271A氨基酸突变所影响的构象变化。
Sci Rep. 2025 Mar 25;15(1):10229. doi: 10.1038/s41598-025-93966-7.
5
The clinical and biochemical effectiveness and safety of cholic acid treatment for bile acid synthesis defects: a systematic review.胆酸治疗胆汁酸合成缺陷的临床及生化有效性与安全性:一项系统评价
Orphanet J Rare Dis. 2024 Dec 19;19(1):466. doi: 10.1186/s13023-024-03449-7.
6
Efficacy and safety of switching therapy from chenodeoxycholic acid to cholic acid in Japanese patients with bile acid synthesis disorders.日本胆汁酸合成障碍患者从鹅去氧胆酸转换为胆酸治疗的疗效和安全性。
Mol Genet Metab Rep. 2024 Nov 22;41:101166. doi: 10.1016/j.ymgmr.2024.101166. eCollection 2024 Dec.
7
The regulatory effects of bioactive polysaccharides on intestinal function and bile acids: chemical structures, bioactivities, and mechanisms.生物活性多糖对肠道功能和胆汁酸的调节作用:化学结构、生物活性及作用机制
Front Nutr. 2024 Nov 15;11:1495993. doi: 10.3389/fnut.2024.1495993. eCollection 2024.
8
Substrate specificity and kinetic mechanism of 3β-hydroxy-Δ-C-steroid oxidoreductase.3β-羟基-Δ-C-甾体氧化还原酶的底物特异性及动力学机制
J Biol Chem. 2024 Dec;300(12):107945. doi: 10.1016/j.jbc.2024.107945. Epub 2024 Nov 4.
9
Spectrum of renal lesions in infantile cholestasis.婴儿胆汁淤积症中的肾脏病变谱
Clin Liver Dis (Hoboken). 2024 Apr 15;23(1):e0150. doi: 10.1097/CLD.0000000000000150. eCollection 2024 Jan-Jun.
10
The changing metabolic landscape of bile acids - keys to metabolism and immune regulation.胆汁酸不断变化的代谢格局——代谢与免疫调节的关键
Nat Rev Gastroenterol Hepatol. 2024 Jul;21(7):493-516. doi: 10.1038/s41575-024-00914-3. Epub 2024 Apr 4.

本文引用的文献

1
Neonatal cholestatic liver disease in an Asian patient with a homozygous mutation in the oxysterol 7alpha-hydroxylase gene.一名亚洲患者患有新生儿胆汁淤积性肝病,其氧甾醇7α-羟化酶基因存在纯合突变。
J Pediatr Gastroenterol Nutr. 2008 Apr;46(4):465-9. doi: 10.1097/MPG.0b013e31815a9911.
2
Inborn errors of bile acid metabolism.先天性胆汁酸代谢异常
Semin Liver Dis. 2007 Aug;27(3):282-94. doi: 10.1055/s-2007-985073.
3
Bile acid treatment alters hepatic disease and bile acid transport in peroxisome-deficient PEX2 Zellweger mice.胆汁酸治疗可改变过氧化物酶体缺陷的PEX2 Zellweger小鼠的肝脏疾病及胆汁酸转运。
Hepatology. 2007 Apr;45(4):982-97. doi: 10.1002/hep.21532.
4
Peroxisome biogenesis disorders.过氧化物酶体生物发生障碍
Biochim Biophys Acta. 2006 Dec;1763(12):1733-48. doi: 10.1016/j.bbamcr.2006.09.010. Epub 2006 Sep 14.
5
Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene.脑腱黄瘤病的临床与分子诊断及CYP27A1基因突变综述
Neurol Sci. 2006 Jun;27(2):143-9. doi: 10.1007/s10072-006-0618-7.
6
Clinical and biochemical spectrum of D-bifunctional protein deficiency.D-双功能蛋白缺乏症的临床和生化谱
Ann Neurol. 2006 Jan;59(1):92-104. doi: 10.1002/ana.20702.
7
FXR, a therapeutic target for bile acid and lipid disorders.
Mini Rev Med Chem. 2005 Aug;5(8):719-27. doi: 10.2174/1389557054553802.
8
Mutation in the sterol 27-hydroxylase gene associated with fatal cholestasis in infancy.与婴儿期致命性胆汁淤积相关的固醇27-羟化酶基因突变。
J Pediatr Gastroenterol Nutr. 2005 Apr;40(4):481-6. doi: 10.1097/01.mpg.0000150419.23031.2a.
9
The Farnesoid X Receptor (FXR) as modulator of bile acid metabolism.
Rev Endocr Metab Disord. 2004 Dec;5(4):319-26. doi: 10.1023/B:REMD.0000045103.00467.9a.
10
Bile acid synthetic defects and liver disease: a comprehensive review.胆汁酸合成缺陷与肝脏疾病:全面综述
Pediatr Dev Pathol. 2004 Jul-Aug;7(4):315-34. doi: 10.1007/s10024-002-1201-8. Epub 2004 Jul 15.

疾病机制:胆汁酸合成的先天性代谢缺陷

Mechanisms of disease: Inborn errors of bile acid synthesis.

作者信息

Sundaram Shikha S, Bove Kevin E, Lovell Mark A, Sokol Ronald J

机构信息

Section of Pediatric Gastroenterology, Hepatology and Nutrition, University of Colorado School of Medicine and The Children's Hospital, CO 80045, USA.

出版信息

Nat Clin Pract Gastroenterol Hepatol. 2008 Aug;5(8):456-68. doi: 10.1038/ncpgasthep1179. Epub 2008 Jun 24.

DOI:10.1038/ncpgasthep1179
PMID:18577977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3888787/
Abstract

Inborn errors of bile acid synthesis are rare genetic disorders that can present as neonatal cholestasis, neurologic disease or fat-soluble-vitamin deficiencies. There are nine known defects of bile acid synthesis, including oxysterol 7alpha-hydroxylase deficiency, Delta(4)-3-oxosteroid-5beta-reductase deficiency, 3beta-hydroxy-Delta(5)-C(27)-steroid dehydrogenase deficiency, cerebrotendinous xanthomatosis (also known as sterol 27-hydroxylase deficiency), alpha-methylacyl-CoA racemase deficiency, and Zellweger syndrome (also known as cerebrohepatorenal syndrome). These diseases are characterized by a failure to produce normal bile acids and an accumulation of unusual bile acids and bile acid intermediaries. Individuals with inborn errors of bile acid synthesis generally present with the hallmark features of normal or low serum bile acid concentrations, normal gamma-glutamyl transpeptidase concentrations and the absence of pruritus. Failure to diagnose any of these conditions can result in liver failure or progressive chronic liver disease. If recognized early, many patients can have a remarkable clinical response to oral bile acid therapy.

摘要

胆汁酸合成先天性缺陷是罕见的遗传性疾病,可表现为新生儿胆汁淤积、神经系统疾病或脂溶性维生素缺乏。已知有九种胆汁酸合成缺陷,包括氧化固醇7α-羟化酶缺乏、Δ(4)-3-氧类固醇-5β-还原酶缺乏、3β-羟基-Δ(5)-C(27)-类固醇脱氢酶缺乏、脑腱黄瘤病(也称为固醇27-羟化酶缺乏)、α-甲基酰基辅酶A消旋酶缺乏和泽尔韦格综合征(也称为脑肝肾综合征)。这些疾病的特征是无法产生正常的胆汁酸,以及异常胆汁酸和胆汁酸中间体的积累。胆汁酸合成先天性缺陷的个体通常表现出血清胆汁酸浓度正常或降低、γ-谷氨酰转肽酶浓度正常且无瘙痒的标志性特征。未能诊断出这些病症中的任何一种都可能导致肝衰竭或进行性慢性肝病。如果早期识别,许多患者对口服胆汁酸治疗可产生显著的临床反应。